Showing results (351-360 of 398) with videos related to
Sort By:
Pageof 40
The New England Journal of Medicine|March 5, 2015
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapyHalle C F Moore, Joseph M Unger, Kelly-Anne Phillips, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast CancerMatteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.NPJ Breast Cancer|May 24, 2022
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trialsSaranya Chumsri, Zhuo Li, Daniel J Serie, et al.Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.JAMA Oncology|December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical TrialAnn H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2022
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in EuropeI Vaz-Luis, M Masiero, G Cavaletti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2024
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast CancerErica L Mayer, Yue Ren, Nikhil Wagle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2020
Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence RiskBarbara Pistilli, Angelo Paci, Arlindo R Ferreira, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast CancerSara M Tolaney, Hao Guo, Sonia Pernas, et al.JAMA|October 13, 2020
Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical TrialElyse R Park, Giselle K Perez, Susan Regan, et al.Pageof 40